A study led by The University of Texas at Austin has identified SC27, an antibody capable of neutralizing all known variants of the COVID-19 virus, opening prospects for universal vaccine development and improved treatments amid ongoing viral evolution. Researchers have identified an antibody capable of neutralizing all known strains of SARS-CoV-2, the virus responsible for COVID-19, and several other SARS-like coronaviruses found in different animals. As part of a new study on hybrid immunity to the virus, the large, multi-institution research team led by The University of Texas at Austin discovered and isolated a broadly neutralizing plasma antibody, called SC27,...